The pharmacology and toxicology of the synthetic cathinone mephedrone (4-methylmethcathinone)

Drug Testing and Analysis

Volumn 3, Issue 7-8, 2011, Pages 454-463

  Dargan, Paul I ^a,b   Sedefov, Roumen ^c   Gallegos, Ana ^c   Wood, David M ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION   (Portugal)

Author keywords

4 methylmethcathinone; Mephedrone; Poisoning; Recreational drugs; Toxicity

Indexed keywords

4-METHYLMETHCATHINONE; ACUTE TOXICITY; CATHINONE; MEPHEDRONE; POISONING; RECREATIONAL DRUGS;

TOXICITY;

4' METHYLMETHCATHINONE; CATHINONE;

ACUTE TOXICITY; AGITATION; ANXIETY DISORDER; BEHAVIOR DISORDER; CONSCIOUSNESS DISORDER; CONVULSION; DELUSION; DRUG BIOAVAILABILITY; DRUG DEPENDENCE; DRUG FATALITY; DRUG SYNTHESIS; DRUG USE; FEVER; HALLUCINATION; HEADACHE; HUMAN; HYPERTENSION; INSOMNIA; MYDRIASIS; NASAL IRRITATION; NAUSEA AND VOMITING; NIGHTMARE; NONHUMAN; PARACITOSIS; PARANOIA; PHARMACODYNAMICS; PREVALENCE; PRIORITY JOURNAL; RESTLESSNESS; REVIEW; SIDE EFFECT; SUICIDAL IDEATION; TACHYCARDIA; THORAX PAIN; TREMOR;

EID: 79960626573     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.312     Document Type: Review

References (58)

1. S. Gibbons, M. Zloh. An analysis of the 'legal high' mephedrone. Bioorg. Med. Chem. Lett. 2010, 20, 4135.
2. EWS: Early warning system. Available at: [14 April 2011].
3. P. I. Dargan, D. M. Wood. Annex 1 to the Risk assessmentreport, Technical Report on Mephedrone, EMCDDA contractCT.10.EPI.057. Guy's and St Thomas' NHS Foundation Trust, London, UK, July 2010, Available at: [14 June 2011].
4. EMCDDA-Europol Joint Report: Joint Report on a new psychoactive substance: 4-methylmethcathinone (mephedrone). Reference 8145/10. Cordrogue 36 San 68. Available at: [14 April 2011].
5. P. I. Dargan, S. Albert, D. M. Wood. Mephedrone use and associated adverse effects in school and college/university students before the UK legislation change. Q.J.M. 2010, 103, 875.
6. Erowid: 4-Methylmethcathinone effects. Available at: [14 April 2011].
7. F. Measham, K. Moore, R. Newcombe, Z. Welch. Tweaking, bombing, dabbing and stockpiling: The emergence of mephedrone and the perversity of prohibition. Drugs Alcohol Today 2010, 10, 14.
8. D. M. Wood, S. L. Greene, P. I. Dargan. Clinical pattern of toxicity associated with the novel synthetic cathinone Mephedrone. Emerg. Med. J. 2010, DOI: 10.1136/emj.2010.092288.
9. D. M. Wood, S. Davies, S. L. Greene, J. Button, D. W. Holt, J. Ramsey, P. I. Dargan. Case series of individuals with analytically confirmed acute mephedrone toxicity. Clin. Tox. 2010, 48, 924.
10. Google Insights Search: Web Search Interest: mephedrone Worldwide, 2004-present. Available at: [14 April 2011].
11. Council Decision: COUNCIL DECISION of 2 December 2010 on submitting 4-methylmethcathinone (mephedrone) to control measures (2010/759/EU). Available at: [5 June 2011].
12. R. Newcombe. Mephedrone. The use of Mephedrone (M-cat, Meow) in Middlesbrough. Lifeline Publications and Research, Manchester, UK. Available at: [14 April 2011].
13. Psychonaut WebMapping Research Group 2009, Mephedrone Report. Institute of Psychiatry, King's College London, London, UK. Available at: [14 April 2011].
14. Erowid: 4-Methylmethcathinone basics. Available at: [14 April 2011].
15. Drugs Forum. Mephedrone and Beta-Ketones. Available at: [14 April 2011].
16. EMCDDA Annual Report 2010: 2010 Annual report on the state of the drugs problem in Europe. Available at: [14 April 2011].
17. EMCDDA Drug Profile: EMCDDA-Drug Profiles: Synthetic Cathinones. Available at: [14 April 2011].
18. J. Hillebrand, D. Olszewski, R. Sedefov. Legal highs on the Internet. Subst. Use Misuse 2010, 45(3), 330.
19. J. Ramsey, P. I. Dargan, M. Smyllie, S. Davies, J. Button, D. W. Holt, D. M. Wood. Buying legal recreational drugs does not mean that you are not breaking the law. Q.J.M. 2010, 103, 777.
20. S. D. Brandt, H. R. Sumnall, F. Measham, J. Cole. Second generation mephedrone. The confusing case of NRG-1. B.M.J. 2010, 341, c3564.
21. S. D. Brandt, H. R. Sumnall, F. Measham, J. Cole. Analyses of second-generation legal highs in the UK: initial findings. Drug Test. Analysis 2010, 2, 377.
22. A. Winstock, L. Mitcheson, J. Marsden. Mephedrone: still available and twice the price. Lancet 2010, 376, 1537.
23. EMCDDA. EWS Guidelines, 2007. Early-warning system on new psychoactive substances-operating guidelines. Publications Office of the European Union, Luxembourg. Available at: [14 April 2011].
24. T. M. Brunt, A. Poortman, R. J. Niesink, W. van den Brink. Instability of the ecstasy market and a new kid on the block: mephedrone.J. Psychopharmacol. 2010, Sep 8, Epub ahead of print.
25. A. R. Winstock, L. R. Mitcheson, P. Deluca, Z. Davey, O. Corazza, F. Schifano. Mephedrone, new kid for the chop? Addiction 2011, 106, 154.
26. D. Dick, C. Torrance. Drugs Survey. Mix Mag. 2010, 225, 44.
27. S. McNamara, S. Stokes, N. Coleman. Head shop compound abuse amongst attendees of the drug treatment centre board. Irish Med. J. 2010, 103, 136.
28. Saem de Burnaga Sanchez. Sur un homologue de l'ephedrine. Bull. Soc. Chim. Fr. 1929, 45, 284.
29. A. Camilleri, M. R. Johnston, M. Brennan, S. Davis, D. G. Caldicott. Chemical analysis of four capsules containing the controlled substance analogues 4-methylmethcathinone, 2-fluoromethamphetamine, alpha-phthalimidopropiophenone and N-ethylcathinone. Forensic Sci. Int. 2010, 197, 59.
30. K. Sikk, P. Taba, S. Haldre, J. Bergquist, D. Nyholm, G. Zjablov, T. Asser, S. M. Aquilonius. Irreversible motor impairment in young addicts-ephedrone, manganism or both? Acta Neurol. Scand. 2007, 115, 385.
31. Y. Sanotsky, R. Lesyk, L. Fedoryshyn, I. Komnatska, Y. Matviyenko, S. Fahn. Manganic encephalopathy due to ephedrone abuse. Movement Disord. 2007, 22, 1337.
32. A. Stepens, I. Logina, V. Liguts, P. Aldins, I. Eksteina, A. Platkājis, I. Mārtinsone, E. Tērauds, B. Rozentāle, M. Donaghy. A Parkinsonian syndrome in methcathinone users and the role of manganese. New Engl. J. Med. 2008, 358, 1009.
33. F. Varlibas, I. Delipoyraz, G. Yuksel, G. Filiz, H. Tireli, N. O. Gecim. Neurotoxicity following chronic intravenous use of Russian cocktail. Clin. Toxicol. (Phila). 2009, 47, 157.
34. M. Selikhova, L. Fedoryshyn, Y. Matviyenko, I. Komnatska, M. Kyrylchuk, L. Krolicki, A. Friedman, A. Taylor, H. R. Jäger, A. Lees, Y. Sanotsky. Parkinsonism and dystonia caused by the illicit use of ephedrone-a longitudinal study. Movement. Disord. 2008, 23, 2224.
35. C. Colosimo, M. Guidi. Parkinsonism due to ephedrone neurotoxicity: a case report. Eur. J. Neurol. 2009, 16, e114.
36. K. Sikk, P. Taba, S. Haldre, J. Bergquist, D. Nyholm, H. Askmark, T. Danfors, J. Sörensen, L. Thurfjell, R. Raininko, R. Eriksson, R. Flink, C. Färnstrand, S. M. Aquilonius. Clinical, neuroimaging and neurophysiological features in addicts with manganese-ephedrone exposure. Acta Neurol. Scand. 2010, 121, 237.
37. M. R. Meyer, J. Wilhelm, F. T. Peters, H. H. Maurer. Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry. Anal. Bioanal. Chem. 2010, 397, 1225.
38. Erowid. 4-Methylmethcathinone reports. Available at: [14 April 2011].
39. D. M. Wood, S. Davies, M. Puchnaewicz, J. Button, R. Archer, H. Ovaska, J. Ramsey, T. Lee, D. W. Holt, P. I. Dargan. Recreational use of mephedrone (4-methylmethcathinone, 4-MMC) with associated sympathomimetic toxicity. J. Med. Toxicol. 2010, 6, 327.
40. Erowid. 4-Methylmethcathinone dose. Available at: [14 April 2011].
41. P. J. Nicholson, M. J. Quinn, J. D. Dodd. Headshop heartache: acute mephedrone meow myocarditis. Heart 2010, 96, 2051.
42. D. James, R. D. Adams, R. Spears, G. Cooper, D. J. Lupton, J. P. Thompson, S. H. Thomas, on behalf of the National Poisons Information Service. Clinical characteristics of mephedrone toxicity reported to the UK National Poisons Information Service. Emerg. Med. J. 2010, Aug 25, Epub ahead of print.
43. E. M. Sammler, P. L. Foley, G. D. Lauder, S. J. Wilson, A. R. Goudie, J. I. O'Riordan. A harmless high? Lancet 2010, 376, 742.
44. R. Hägerkvist, P. Hultén, M. Personne. Increasing abuse of new cathinone derivatives in Sweden-a poisons centre study for the years 2008-2009. Clin. Toxicol. 2010, 48, 291.
45. L. Regan, M. Mitchelson, C. Macdonald. Mephedrone toxicity in a Scottish emergency department. Emerg. Med. J. DOI:10.1136/emj.2010.103093.
46. Belfast Telegraph: Anonymous. Missing mephedrone boy's body found, 30th April 2010. Available at: [14 April 2011].
47. rd March 2010. Available at: [14 April 2011].
48. th March 2010. Available at: [14 April 2011].
49. Daily Mail: James Slack. Is Lois, 24, victim number six of 'legal high' meow meow drug? 24 March 2010. Available at: [14 April 2011].
50. Daily Mail: Chris Brooke. Action pledged on 'Meow, Meow' drug after two teen friends die within hours of taking legal high, 14 April 2010. Available at: [14 April 2011].
51. The Guardian: Paul Walker. Three arrested over suspected mephedrone deaths, 17 March 2010. Available at: [14 April 2011].
52. The Sun: Staff Reporter. Two held over meow deaths, 16 March 2010. Available at: [14 April 2011].
53. th January 2010. Available at: [14 April 2011].
54. D. Gustavsson, C. Escher. Mephedrone-Internet drug which seems to have come and stay. Fatal cases in Sweden have drawn attention to previously unknown substance. Lakartidningen 2009, 106, 2769.
55. H. Torrance, G. Cooper. The detection of mephedrone (4-methylmethcathinone) in 4 fatalities in Scotland. Forensic Sci. Int. 2010, 202, e62.
56. A. J. Dickson, S. P. Vorce, B. Levine, M. R. Past. Multiple-drug toxicity caused by coadministration of 4-methylmethcathinon (mephedrone) and heroin. J. Anal. Toxicol. 2010, 34, 162.
57. A. H. Ghodse, J. Corkery, K. Ahmed, V. Naidoo, A. Oyefeso, F. Schifano. Drug Related Deaths in the UK, Annual Report 2010. International Centre for Drug Policy: St George's, University of London, UK, 2010.
58. N. Bajaj, D. Mullen, S. Wylie. Dependence and psychosis with 4-methylmethcathinone (mephedrone) use. B.M.J. Case Reports 2010, DOI:10.1136/bcr.02.2010.2780.